StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly alimta (pemetrexed) — Worldwide revenue ($M) [legacy separate disclosure] ($M)

Form 10-Q / 10-K Note 2 & MD&A (legacy separate product disclosure prior to FY2025 reorganization)

QuarterlyAnnual
Latest, Q4 2023
44.9
Period ended Dec 31, 2023
Change on a year earlier
-81.0%
237 in Q4 2022
History
28 quarters
Since Q1 2017
Sources
24
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAlimta (pemetrexed) — Worldwide revenue ($M) [legacy separate disclosure] ($M)Year on yearSource
Q4 2023Dec 31, 202344.9-81.0%Earnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 202353.5-55.2%Form 10-Q (filed 2023-11-02) ↗
Q2 2023Jun 30, 202360.9-73.3%Form 10-Q (filed 2023-08-08) ↗
Q1 2023Mar 31, 202358.2-83.1%Form 10-Q (filed 2023-04-27) ↗
Q4 2022Dec 31, 2022237-45.6%Earnings Release (Form 8-K FY2022Q4 EX-99.1) (filed 2023-02-02) ↗
Q3 2022Sep 30, 2022119-73.9%Form 10-Q (filed 2023-11-02) ↗
Q2 2022Jun 30, 2022228-62.7%Form 10-Q (filed 2023-08-08) ↗
Q1 2022Mar 31, 2022344-38.5%Form 10-Q (filed 2023-04-27) ↗
Q4 2021Dec 31, 2021435-33.4%Earnings Release (Form 8-K FY2021Q4 EX-99.1) (filed 2022-02-03) ↗
Q3 2021Sep 30, 2021457-20.9%Form 10-Q (filed 2022-11-01) ↗
Q2 2021Jun 30, 2021611+13.3%Form 10-Q (filed 2022-08-04) ↗
Q1 2021Mar 31, 2021559-0.2%Form 10-Q (filed 2022-04-29) ↗
Q4 2020Dec 31, 2020653+23.0%Earnings Release (Form 8-K FY2020Q4 EX-99.1) (filed 2021-01-29) ↗
Q3 2020Sep 30, 2020578+13.7%Form 10-Q (filed 2021-10-27) ↗
Q2 2020Jun 30, 2020539-6.7%Form 10-Q (filed 2021-08-03) ↗
Q1 2020Mar 31, 2020560+12.2%Form 10-Q (filed 2021-04-30) ↗

Breakdown

What makes up alimta (pemetrexed) — worldwide revenue ($m) [legacy separate disclosure]

Cite this data

StockData. (2026). Eli Lilly Alimta (pemetrexed) — Worldwide revenue ($M) [legacy separate disclosure] ($M), quarterly Q1 2017–Q4 2023 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med_alimta_ww

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.